From a prognostic standpoint, our previous report highlights the significant negative prognostic impact of pooled mutations involving KRAS p.G12C and p.G12S in patients with mCRC (STORIA study: Study of Ras mutations prognostic value in metastatic colorectal cancer) [8]. The gene discussed is KRAS; the disease is metastatic colorectal cancer.